OrthoPediatrics (NASDAQ:KIDS) Earns Buy Rating from Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of OrthoPediatrics (NASDAQ:KIDS) in a research report released on Tuesday,Benzinga reports. They currently have a $42.00 price objective on the stock.

Separately, Truist Financial cut their target price on shares of OrthoPediatrics from $28.00 to $25.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th.

OrthoPediatrics Stock Performance

KIDS opened at $26.53 on Tuesday. OrthoPediatrics has a 12-month low of $21.02 and a 12-month high of $35.99. The firm has a market capitalization of $642.45 million, a P/E ratio of -21.57 and a beta of 1.14. The stock’s 50 day moving average price is $23.95 and its two-hundred day moving average price is $27.36. The company has a quick ratio of 3.68, a current ratio of 7.17 and a debt-to-equity ratio of 0.19.

Institutional Trading of OrthoPediatrics

Several institutional investors have recently modified their holdings of KIDS. Wellington Management Group LLP boosted its stake in OrthoPediatrics by 16.2% during the third quarter. Wellington Management Group LLP now owns 883,221 shares of the company’s stock worth $23,944,000 after buying an additional 122,846 shares in the last quarter. State Street Corp lifted its holdings in shares of OrthoPediatrics by 1.0% during the 3rd quarter. State Street Corp now owns 417,898 shares of the company’s stock worth $11,329,000 after acquiring an additional 4,236 shares during the period. Geode Capital Management LLC boosted its position in shares of OrthoPediatrics by 2.1% during the 3rd quarter. Geode Capital Management LLC now owns 391,492 shares of the company’s stock valued at $10,615,000 after acquiring an additional 7,972 shares in the last quarter. Portolan Capital Management LLC boosted its position in shares of OrthoPediatrics by 66.2% during the 3rd quarter. Portolan Capital Management LLC now owns 308,099 shares of the company’s stock valued at $8,353,000 after acquiring an additional 122,770 shares in the last quarter. Finally, Harbor Capital Advisors Inc. increased its stake in OrthoPediatrics by 1.9% in the fourth quarter. Harbor Capital Advisors Inc. now owns 251,588 shares of the company’s stock valued at $5,832,000 after acquiring an additional 4,728 shares during the period. Institutional investors and hedge funds own 69.05% of the company’s stock.

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.